Dr KK Aggarwal

The ambitious National Digital Health Mission under which every Indian will get a health ID has many pros. But there are also concerns about privacy and confidentiality which should be addressed

As more and more drug trials take place in the time of Covid-19, the industry needs to be more open and put most of the data in the public domain to remove opacity, retain trust and to serve as a useful database

In order to better understand the disease, ICMR has mooted a proposal for a registry. This powerful tool will analyse data of all Covid-19 patients in hospitals and should include those being home-managed.

New breakthrough technol...

The Assam government has...

Even though recovery is the rule rather than the exception in the case of this pandemic, irrational fears among healthcare workers have affected the treatment of these patients

Though the ICMR is aiming for an August 15 deadline, it is a moot question whether a timeline can be issued when different phases and trials have to be done to ensure safety.

While plasma therapy has been touted as a remedy for corona, there can be transfusion reactions or the disease worsening. This includes acute lung injury or acute respiratory distress

The Covid-19 pandemic ha...

All people should consid...